Jeena Sikho Lifecare Ltd (JSLL) — Announcement | 29 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company to attend Ashwamedh-Elara India Dialogue 2026 on September 3, 2026.
💡 Investor Takeaway
Investors can observe management discussions without new price-sensitive disclosures.

Jeena Sikho Lifecare Ltd announced it will attend the Twelfth Edition of the Ashwamedh-Elara India Dialogue 2026 on September 3, 2026, at Grand Hyatt, Santacruz, Mumbai, from 10:00 AM to 5:00 PM, as part of its regulatory investor engagement under SEBI's LODR Regulation 30.

📄 View Original Announcement (PDF)

About Jeena Sikho Lifecare Ltd (JSLL)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹6,347.42 Cr P/E: 26.9 ROE: 187.8% ROCE: 261.5% Div Yield: 0.88%

View full JSLL stock details →

📡 Get AI alerts when JSLL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JSLL — Free

📊 More JSLL filings

See all JSLL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JSLL files new disclosures

Track JSLL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JSLL — Free

Free account · 2 AI queries/day